Psychometric properties of an index of three patient-reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study

Clinical and Experimental Rheumatology

Volumn 28, Issue 2, 2010, Pages 186-200

  Salaffi, Fausto ^a   Migliore, Alberto ^b   Scarpellini, Magda ^c   Corsaro, Santi Michelangelo ^d   Laganà, Bruno ^e   Mozzani, Flavio ^f   Varcasia, Giuseppe ^g   Pusceddu, Mariangela ^h   Pomponio, Giovanni ^a   Romeo, Nicoletta ⁱ   Maier, Armin ^j   Foti, Rosario ^k   Scarpa, Raffaele ^l   Gasparini, Stefania ^a   Bombardieri, Stefano ^m  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c Ospedale di Magenta   (Italy)

^d Ospedale San Giovanni Bosco   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Azienda Ospedaliera   (Italy)

^g ASP   (Italy)

^h Ospedale di Iglesias   (Italy)

ⁱ S CROCE E CARLE HOSPITAL   (Italy)

^j Ospedale Centrale   (Italy)

^k Azienda Ospedaliera Universitaria   (Italy)

^l UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^m UNIVERSITY OF PISA   (Italy)

more..

Author keywords

Composite indices; Disease activity; Patient reported outcome; PRO CLARA; Reliability; Rheumatoid arthritis; Validity

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CONCURRENT VALIDITY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; CROSS-SECTIONAL STUDY; DISCRIMINANT VALIDITY; DISEASE ACTIVITY; FACTORIAL ANALYSIS; FEASIBILITY STUDY; FEMALE; HEALTH STATUS; HUMAN; INTERNAL CONSISTENCY; ITALY; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; REMISSION; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 77952782434     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. SALAFFI F, DE ANGELIS R, GRASSI W: MArche Pain Prevalence; Investigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005; 23: 819-828
2. ALETAHA D, LANDEWE R, KARONITSCH T et al.: Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 2008; 67: 1360-1364
3. FELSON DT: Choosing a core set of disease activity measures for rheumatoid arthritis clinical trials. J Rheumatol 1993; 20: 531-534
4. FELSON DT, ANDERSON JJ, BOERS M et al.: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-735
5. AMERICAN COLLEGE OF RHEUMATOLOGY COMMITTEE TO RE-EVALUATE IMPROVEMENT CRITERIA: A Proposed Revision to the ACR20: The Hybrid Measure of American College of Rheumatology Response. Arthritis Rheum 2007; 57: 193-200.
6. VAN DER HEIJDE DMFM, VAN'T HOF MA,VAN RIEL PLCM et al.: Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916-920
7. PREVOO ML, VAN'T HOF MA, KUPER HH et al.: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48
8. SMOLEN JS, BREEDVELD FC, SCHIFF MH et al.: A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 244-257
9. ALETAHA D, NELL VP, STAMM T et al.: Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R 796-806.
10. MÄKINEN H, KAUTIAINEN H, HANNONEN P et al.: A New Disease Activity Index for Rheumatoid Arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA). J Rheumatol 2008; 35: 1522-1527
11. RITCHIE DM, BOYLE JA, MCINNES JM et al.: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968; 37: 393-406.
12. VAN GESTEL AM, PREVOO ML, VAN'T HOF MA et al.: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996; 39: 34-40.
13. FRANSEN J, BERNELOT MOENS H, SPEYER I et al.: Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005; 64: 1294-1298
14. GRIGOR C, CAPELL H, STIRLING A et al.: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 263-269
15. GOEKOOP-RUITERMAN YPM, DE VRIESBOUWSTRA JK, ALLAART CF et al.: Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005; 52: 3381-3390
16. GOEKOOP-RUITERMAN YPM, DE VRIESBOUWSTRA JK, ALLAART CF et al.: Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 2007; 146: 406-415
17. VERSTAPPEN SMM, JACOBS JWG, VAN DER VEEN MJ et al.: Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007; 66: 1443-1449
18. BAKKER MF, JACOBS JWG, VERSTAPPEN SMM et al.: Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Ann Rheum Dis 2007; 66 (Suppl. III): iii56-iii60.
19. WICK MC, LINDBLAD S, KLARESKOG L et al.: Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description. Ann Rheum Dis 2004; 63: 848-852
20. KORPELA M, LAASONEN L, HANNONEN P et al.: Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs. Arthritis Rheum 2004; 50: 2072-2081
21. PINCUS T, SEGURADO OG: Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis 2006; 65: 820-822
22. WONG AL, WONG WK, HARKER J et al.: Patient self-report tender and swollen joint counts in early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. J Rheumatol 1999; 26: 2551-2561
23. HOUSSIEN DA, STUKI G, SCOTT DL: A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research. Rheumatology 1999; 38: 48-52.
24. FELSON DT, ANDERSON JJ, BOERS M et al.: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 729-740
25. TUGWELL P, BOERS M: OMERACT Committee. Proceedings of the OMERACT Conferences on outcome measures in rheumatoid arthritis clinical trials, Maastrict, Netherlands. J Rheumatol 1993; 20: 527-591
26. PINCUS T, V. STRAND V, G. KOCH G et al.: An index of the three Core Data Set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as Effectively as the American College of Rheumatology 20% Response Criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 2003; 48: 625-630
27. SOKKA T, HAKKINEN A, KRISHNAN E et al.: Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis 2004; 63: 494-497
28. PINCUS T, AMARA I, KOCH GG: Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis Rheum 2005; 52: 1031-1036
29. WOLFE F, MICHAUD K, PINCUS T: A composite disease activity scale for clinical practice, observational studies and clinical trials: the patient activity scale (PAS/PAS-II). J Rheumatol 2005; 32: 2410-2415
30. STUCKI G, LIANG MH, STUCKI S et al.: A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995; 38: 795-798
31. VEEHOF MM, TEN KLOOSTER PM, TAAL E et al.: Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting antitumour necrosis factor treatment. Ann Rheum Dis 2008; 67; 789-793
32. LEEB BF, HAINDL PM, MAKTARI A et al.: Patient-Centered Rheumatoid Arthritis Disease Activity Assessment by a Modified RADAI. J Rheumatol 2008; 35: 1294-1299 (Pubitemid 352000773)
33. PINCUS T, M. J. BERGMAN MJ, YAZICI Y et al.: An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology 2008; 47: 345-349
34. PINCUS T, SWEARINGEN CJ, BERGMAN M et al.: RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol 2008; 35: 2136-2147
35. PINCUS T, YAZICI Y, SOKKA T: Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol 2007; 21: 601-608
36. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324
37. MÖTTÖNEN T, HANNONEN P, LEIRISALOREPO M et al.: Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999; 353: 1568-1573
38. BOERS M, TUGWELL P, FELSON DT et al.: World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 1994; 41: 86-89
39. WELLS GA, BOERS M, SHEA B et al.: Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol 2005; 32: 2016-2024 (Pubitemid 41429036)
40. PINALS RS, MASI AT, LARSEN RA: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308-1315 (Pubitemid 11022943)
41. FRANSEN J, CREEMERS MC, VAN RIEL PL: Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004; 43: 1252-1255 (Pubitemid 39359299)
42. PREVOO ML, VAN GESTEL AM, VAN'T HOF MA et al.: Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996; 35: 1101-1105
43. SALAFFI F, STANCATI A, NERI R et al.: Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S31-42.
44. SALAFFI F, BAZZICHI L, STANCATI A et al.: Development of a functional disability measurement tool to assess early arthritis: the Recent-Onset Arthritis Disability (ROAD) questionnaire. Clin Exp Rheumatol 2005; 23: 628-636
45. FRIES JF, SPITZ P, KRAINES RG et al.: Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-145
46. RANZA R, MARCHESONI A, CALORI G et al.: The Italian version of the functional disability index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol 1993; 11: 123-128
47. ALETAHA D, WARD MM, MACHOLD KP et al.: Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005; 52: 2625-2636
48. ALETAHA D, SMOLEN JS: The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin North Am 2006; 32: 9-44, vii.
49. MASON JH, ANDERSON JJ, MEENAN RF et al.: The rapid assessment of of disease activity in rheumatology (RADAR) questionnaire. Arthritis Rheum 1992; 35: 156-162
50. PINCUS T, YAZICI Y, BERGMAN M, MACLEAN R, HARRINGTON T: A proposed continuous quality improvement approach to the assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). Best Pract Res Clin Rheumatol 2007; 21: 789-804.
51. YAZICI Y, BERGMAN M, PINCUS T: Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores. J Rheumatol 2008; 35: 603-609
52. KIRSHNER B, GUYATT GH: Methodological framework for assessing health indices. J Chron Dis 1985; 1: 27-36
53. - OXMAN AD, GUYATT GH: Validation of an index of the quality of review articles. J Clin Epidemiol 1991; 44: 1271-1278
54. NUNNALLY JC: Psychometric Theory. 2nd ed. New York: McGraw Hill, 1978.
55. SKINNER HA: Factor analysis and studies on alcohol. A methodological review. J Studies Alcohol 1980; 41: 1091-1101
56. MUNRO BH: Statistical methods for health care research. 3rd ed. New York: Lippincott Williams & Wilkins, 1997.
57. SWETZ JA: Measuring accuracy of diagnostic systems. Science 1988; 240: 1285-1293
58. HAULEY JA, MCNEIL BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843
59. BENTLEY MJ, REED CW: Simplified composite disease activity measures in rheumatoid arthritis: should they used in standard care?. Clin Exp Rheumatol 2008; 26: 358-366
60. SMOLEN JS, SOKKA T, PINCUS T et al.: A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures. Clin Exp Rheumatol 2003; 21 (Suppl. 31): 209-210
61. WELSING PM, LANDEWE RB, VAN RIEL PL et al: The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004, 50: 2082-2093
62. WOLFE F, PINCUS T, THAMPSON AK et al.: The assessment of rheumatoid arthritis and the acceptability of self-report questionnaire in clinical practices. Arthritis Rheum 2003; 49: 59-63.
63. CUSH JJ: Biological drug use: US perspectives on indications and monitoring. Ann Rheum Dis 2005; 64: iv18-iv23.
64. GOSSEC L, DOUGADOS M, RINCHEVAL N et al.: The elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis doi:10.1136/ard.2008.100271.
65. PINCUS T, MACLEAN R, YAZICI Y et al.: Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as a continuous quality improvement activity, rather than traditional research. Clin Exp Rheumatol 2007; 23 (Suppl. 47): S69-S81.
66. LEVY G, CHEETHAM C, CHEATWOOD A et al.: Validation of patient-reported joint counts in rheumatoid arthritis and the role of training. J Rheumatol 2007; 34: 1261-1265
67. SOKKA T, HAUGEBERG G. PINCUS T: Assessment of quality of rheumatoid arthritis care requires joint count and/or patient questionnaire data not found in a usual medical record: examples from studies of premature mortality, changes in clinical status between 1985 and 2000, and a QUEST-RA global perspective. Clin Exp Rheumatol 2007; (Suppl. 47): S86-S97.
68. HEIBERG T, KVIEN TK, MOWINCKEL P et al.: Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 967-971
69. SALAFFI F, GASPARINI S, GRASSI W: The use of computer touch-screen technology for the collection of patient-reported outcome data in rheumatoid arthritis: comparison with standardized paper questionnaires. Clin Exp Rheumatol 2009; 27: 459-468
70. VELIKOVA G, SMITH AB, CULL A et al.: Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Onc 1999; 17: 998-1007.
71. GREENWOOD MC, HAKIM AJ, CARSON E et al.: Touch-screen computer systems in the rheumatology clinic offer a reliable and user-friendly means of collecting quality-of-life and outcome data from patients with rheumatoid arthritis. Rheumatology 2006: 45: 66-71.
72. BISHOFF-FERRARI HA, VONDECHEND M, BELLAMY N et al.: Validation and patient acceptance of a computer touch-screen version of the WOMAC 3.1 osteoarthritis index. Ann Rheum Dis 2005; 64: 80-84
73. FRANSEN J, HAUSELMANN H, MICHEL BA et al.: Responsiveness of the self-assessed rheumatoid arthritis disease activity index to a flare of disease activity. Arthritis Rheum 2001; 44: 53-60.
74. SAAG KG, TENG GG, PATKAR NM et al.: American College of Rheumatology 2008 recommendations for the use of non biologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59: 762-784
75. LEWIS PA, O'SULLIVAN MM, RUMFELD WR et al.: Significant changes in Ritchie scores. Br J Rheumatol 1988; 27: 32-36
76. PINCUS T, YAZICI Y, BERGMAN M et al.: A proposed approach to recognise "near-remission" quantitatively without formal joint counts or laboratory tests: a patient selfreport questionnaire routine assessment of patient index data (RAPID) score as a guide to a "continuous quality improvement" strategy. Clin Exp Rheumatol 2006; 24 (Suppl. 43): S60-S73.
77. SALAFFI F, FILIPPUCCI E, CAROTTI M et al.: Inter observer agreement of standard joint counts in early rheumatoid arthritis: a comparison with grey scale ultrasonography - a preliminary study. Rheumatology 2008; 47: 54-58
78. CALVO FA, CALVO A, BERROCAL A et al.: Self-administered joint counts in rheumatoid arthritis: comparison with standard joint counts. J Rheumatol 1999; 26: 536-539
79. SOKKA T, KAUTIAINEN H, MOTTONEN T et al.: Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999; 26: 1681-1685
80. LEARDINI G, SALAFFI F, MONTANELLI R et al.: A multicenter cost-of-illness study on rheumatoid arthritis in Italy. Clin Exp Rheumatol 2002; 20: 505-515
81. WOLFE F, ZWILLICH SH: The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1072-1082
82. WOLFE F, CATHEY MA: The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 1991; 18: 1298-1306
83. RUSSAK SM, CROFT JD, FURST DE et al.: The use of rheumatoid arthritis health-related quality of life patient questionnaires in clinical practice: lessons learned. Arthritis Care Res 2003; 49: 574-584
84. LEEB BF, HAINDL PM, MAKTARI A et al.: Disease activity score-28 values differ considerably depending on patient's pain perception and sex. J Rheumatol 2007; 34: 2382-2387
85. VAN DER HEIJDE DM, VAN'T HOF M, VAN RIEL PL et al.: Development of a disease activity score based on judgement in clinical practice by rheumatologiusts. J Rheumatol 1993; 20: 579-581
86. SALAFFI F, CIMMINO MA, G. LEARDINI G et al.: on Behalf of the Epidemiology Study Group of the Italian Society of Rheumatology. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). Clin Exp Rheumatol 2009; 27: 552-559
87. ALETAHA D, SMOLEN J: The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S100-8.
88. RANGANATHVK, YOON J, KHANNA D et al.: Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis 2007; 66: 1633-1640